Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%)

Intensive Care Medicine

Volumn 21, Issue 7, 1995, Pages 577-583

  Degremont A C ^a   Ismail M ^b   Arthaud, M ^c   Oulare, B ^d   Mundler, O ^e   Paris, M ^d   Baron, J F ^d  

^a Hôpial Tenon ^*  (France)

^b Hop Pitie Salpetriere   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL BROUSSAIS   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Hydroxyethyl starch; Pharmacokinetics; Plasma volume

Indexed keywords

ALBUMIN; HETASTARCH; PLASMA SUBSTITUTE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; DIURESIS; GEL PERMEATION CHROMATOGRAPHY; GENERAL ANESTHESIA; HEMODYNAMICS; HUMAN; HYDROLYSIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MOLECULAR WEIGHT; ONCOTIC PRESSURE; PLASMA VOLUME; POSTOPERATIVE PERIOD; TIME;

AGED; DRUG MONITORING; ENDARTERECTOMY, CAROTID; HEMODYNAMICS; HUMAN; HYDROLYSIS; INFUSIONS, INTRAVENOUS; MIDDLE AGE; MOLECULAR WEIGHT; OSMOTIC PRESSURE; PLASMA SUBSTITUTES; PLASMA VOLUME; POLYMERS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; STARCH; TIME FACTORS;

EID: 0029156875     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/BF01700163     Document Type: Article

References (39)

1. Hydroxyethyl starch
2. Persistence for starch derivative and dextran when infused after hermorrhage
3. Studies on hydroxyethyl starch. Part I: Molecular characterization by size exclusion chromatography coupled with low angle laser light sattering
4. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic and septic shock
5. Intracranial bleeding during treatment with hydroxyethyl starch
6. Long term intravascular persistence of hydroxyethyl starch in man
7. Clinical investigations of a new plasma expander partially substituted HES
8. The elimination of hydroxyethyl Starch 200/0.5, dextran 40 and oxypolygelatin
9. A clinical study of low molecular weight hydroxyethyl starch, a new plasma expander
10. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations
11. Effects of Elohes and albumin on haemostasis in orthopaedic surgery
12. Changes in the molecular compostion of circulating hydroxyethyl starch following consecutive daily infusions in man
13. Studies on hydroxyethyl starch. Part II: changes of the molecular weight distribution of hydroxyethyl starch types 450/0.7, 450/0.5, 450/0.3, 300/0.4, 200/0.7, 200/0.5, 200/0.3, 200/0.1 after infusion in urine and serum of volonteers
14. Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders
15. Billilary excretion of hydroxyethyl starch in man
16. Albumin abuse in intensive care medicine
17. Standard techniques for the measurement of red cell and plasma volume
18. The body venous haematocrit ratio and its use for calculating total blood volume from fractional volumes
19. A clinical physiologic study of hydroxyethyl starch
20. Transcapillary escape rate of albumin and plasma volume in essential hypertension
21. Fluid volume and albumin kinetics occuring with major surgery
22. Clinical investigation of HES in respect of circulatory movement, metabolism and excretion
23. Pharmakokinetische Merkmale als Kriterien für den klinischen Einsatz von Hydroxyethylstärke
24. Hetastarch: an over view of the colloid and its metabolism
25. Macroamylasaemia after treatment with hydroxyethyl starch
26. Pentafraction-Du Pont versus albumin for resuscitation of a lethal intestinal ischemic shock in rats
27. Physiology and pathophysiology of colloid osmotic pressure and albumin metabolism
28. Simultaneous red cell mass and plasma volume determination using 51 Cr tagged red cells and 125-l labelled albumin
29. The elution of 99 m Tc from red cells and its effect on red cells volume measurement
30. Hemodynamic and hormonal effects of normovolemic hemodilution using hydroxyethyl starch
31. Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution
32. Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy
33. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion
34. Importance of thoracic duct lymph in restitution of plasma volume and plasma proteins after bleeding and immediate substitution in the splenectomized dog
35. Blutvolumen, kolloidaler osmotischer Druck und Nierenfunktion von Probanden nach Infusion mittelmolekularer 10% Hydroxyethylstärke 200/0.5 und 10% dextran 40
36. Extravascular albumin
37. Albumin synthesis
38. Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy
39. Regulation of glomerular filtration rate and sodium excretion by angiotensin II